查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1820001

2025 年至 2033 年脊椎生物製剂市场报告（按产品、手术类型、最终用户和地区）

Spine Biologics Market Report by Product, Surgery Type, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球脊椎生物製剂市场规模达21.4亿美元。展望未来， IMARC Group预计到2033年，市场规模将达到29.7亿美元，2025-2033年期间的复合年增长率（CAGR）为3.52%。推动市场发展的因素包括：微创手术（MIS）的广泛应用、老年人口的成长、收入水准提高带来的医疗服务可近性的提升，以及脊椎疾病发生率的上升。

脊椎生物製剂市场分析：

  • 主要市场驱动因素：脊椎生物製剂市场研究表明，市场主要受到椎间盘疾病和椎管狭窄等脊椎疾病盛行率不断上升的推动，这些疾病通常与老化和生活方式因素有关。
  • 主要市场趋势：随着医疗技术的进步，脊椎手术中生物製剂的使用日益明显，以促进患者更快康復并获得更好的治疗效果。在脊椎生物製剂市场预测中，该产业将见证人工智慧和机器学习技术的持续创新，从而提高脊椎生物製剂的精准度和有效性。
  • 地理趋势：北美凭藉其先进的医疗基础设施、高昂的医疗支出以及对脊椎疾病的认知度，目前在全球市场占据领先地位。此外，根据脊椎生物製剂市场统计数据，由于医疗保健服务的普及、经济水平的提高以及老年人口的增长，亚太地区正经历快速增长。
  • 竞争格局：脊椎生物製剂产业的一些主要市场参与者包括 Arthrex Inc.、Alphatec Holdings Inc.、Exactech Inc.、强生、美敦力公司、NuVasive Inc.、Orthofix Medical Inc.、Stryker Corporation、Wright Medical Group NV 和 Zimmer Biomet 等。
  • 挑战与机会：市场挑战包括对生物製剂高成本的担忧，以及可能导致产品上市延迟的严格监管环境。正如脊椎生物製剂市场概述所述，与保险公司和医疗机构日益增多的合作，有望改善生物製剂治疗的可及性和应用，从而创造众多机会。

脊椎生物製剂市场趋势：

脊椎疾病盛行率不断上升

脊椎疾病的日益增加影响着脊椎生物製剂市场的成长。此外，预期寿命的延长和生活方式的问题也刺激了椎间盘疾病和椎管狭窄等退化性疾病的发展。根据世界卫生组织 (WHO) 的数据，2020 年大约每 13 个人中就有 1 人（相当于 6.19 亿人）患有腰痛 (LBP)，比 1990 年增加了 60%。据进一步估计，到 2050 年，腰痛病例将增加约 8.43 亿，凸显了脊椎问题的普遍性。 80 岁年龄层的发生率不断上升，而 50-55 岁年龄层的 LBP 病例数则不断增加。这种普遍的盛行率需要持续开发和部署有效的治疗方法，包括生物製剂，这有助于促进骨骼生长和癒合，使其成为治疗这些普遍存在的疾病的关键。

微创手术（MIS）的采用率不断上升

与传统的开放式手术相比，微创手术 (MIS) 因其痛苦小、恢復快而成为治疗脊椎疾病的首选。根据 IMARC 集团的数据，预计 2024 年至 2032 年期间，全球微创手术市场将以约 6% 的年复合成长率(CAGR) 扩张。 2023 年，该市场规模达到 529 亿美元，预计到 2032 年将达到 910 亿美元。这一增长表明手术方法的转变，从而缩短了住院时间和恢復期，这对脊椎生物製剂的市场价值尤其有利。

老年人口不断增加

老年人口的成长推动了脊椎生物製剂市场的需求。随着年龄的增长，脊椎疾病的风险也会增加，因此需要更频繁、更深入的照护。根据联合国的资料，预计65岁及以上人口的比例将从2022年的10%上升到2050年的16%。预计到2050年，全球65岁及以上人口的数量将是5岁以下儿童数量的两倍，相当于12岁儿童的数量。这意味着与年龄相关的脊椎疾病数量将持续增加，对有效且微创的治疗方法的需求也随之增加。例如，有助于自然癒合过程的生物製剂尤其适合满足这些需求，符合全球老化人口日益增长的医疗保健需求。

脊椎生物製剂市场细分：

按产品分类：

  • 脊椎同种异体移植
    • 机械加工骨同种异体移植
    • 去矿骨基质
  • 骨移植替代品
    • 骨形态发生蛋白
    • 合成骨移植
  • 基于单元格的矩阵

骨移植替代品占大部分市场份额

骨移植替代品是传统骨移植的替代方案，可在脊椎手术中提供结构支撑并促进骨癒合。这些替代品包括合成材料、同种异体骨和脱矿骨基质，因其能够促进骨融合、减少从患者自身取骨的需求、最大限度地减少手术併发症和缩短恢復时间而备受推崇。根据IMARC GROUP的数据，全球骨移植和替代品市场规模在2023年达到32亿美元。预计到2032年将达到51亿美元，2024-2032年期间的年复合成长率（CAGR）为5.2%。此外，生物材料、再生医学和骨移植替代品领域的各项进步正见证着其在脊椎手术中的应用日益广泛，从而积极提升了脊椎生物製品市场的价值。

依手术类型分类：

  • 开放性脊椎手术
  • 微创脊椎手术

微创脊椎手术占据业界最大份额

微创脊椎手术的兴起主要归功于患者和医护人员对微创手术的日益青睐。与传统的开放式手术相比，微创脊椎手术具有许多优势，包括切口较小、出血量较少、住院时间较短、恢復较快。因此，它在治疗各种脊椎疾病方面广受欢迎，例如退化性椎间盘疾病、椎间盘突出、椎管狭窄和椎体骨折。根据美国国家医学图书馆的数据，随着影像导航系统、机器人技术和内视镜技术的进步，微创脊椎 (MIS) 手术取得了显着进展。美国每年完成的微创脊椎手术超过 40 万例，其中脊椎融合术是治疗脊椎创伤、肿瘤、结构畸形和退化性疾病的常用且成熟的治疗方案。

按最终用户分类：

  • 医院
  • 门诊护理中心
  • 脊椎外科中心
  • 骨科诊所
  • 其他的

医院是主要的细分市场

医院是主要的专科医疗中心，吸引了大量寻求各种脊椎疾病（包括需要手术治疗的疾病）的患者。此外，一些医院设有专门的脊椎中心或科室提供服务，使其成为提供全面护理的首选中心。此外，医院与脊椎生物製剂製造商和供应商保持着密切的合作，从而提高了设备的效率。 2022年6月，Xenco Medical 获得美国食品药物管理局 (FDA) 的批准，并推出了一次性使用的多节段颈椎手术套件 (Multilevel CerviKit)，从而扩大了其面向门诊手术中心的设备范围。该套件包含一整套用于颈椎前路两节段、三节段和四节段手术的植入物和一次性器械。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美引领市场，占据脊椎生物製剂最大市场份额

该报告还对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告指出，北美是脊椎生物製剂最大的区域市场。

北美在市场上的主导地位可以归因于高度发展的医疗基础设施、创新医疗技术的高采用率以及庞大的脊椎疾病患者群体。例如，根据美国国家脊髓损伤协会的资料，美国约有 45 万人患有脊髓损伤 (SCI)。美国每年估计有 17,000 例新发生 SCI 病例，主要源自于脊椎创伤。因此，SCI 族群发病率的上升显着增加了该地区对治疗脊椎疾病的生物製剂的需求。此外，优惠的报销政策、强大的研发力度以及对微创手术优势的认识，正在为北美脊椎生物製剂市场带来收入。

本报告回答的关键问题

  • 全球脊椎生物製剂市场有多大
  • 2025-2033年全球脊椎生物製剂市场的预期成长率是多少
  • 推动全球脊椎生物製剂市场的关键因素有哪些
  • COVID-19 对全球脊椎生物製剂市场有何影响
  • 根据产品类型，全球脊椎生物製剂市场如何划分？
  • 根据手术类型，全球脊椎生物製剂市场如何分布
  • 根据最终用户，全球脊椎生物製剂市场如何划分
  • 全球脊椎生物製剂市场的主要区域有哪些
  • 全球脊椎生物製剂市场的主要参与者/公司有哪些

本报告回答的关键问题

  • 全球脊椎生物製剂市场有多大？ 2025-2033年全球脊椎生物製剂市场的预期成长率是多少？
  • 推动全球脊椎生物製剂市场发展的关键因素有哪些？
  • COVID-19 对全球脊椎生物製剂市场有何影响？
  • 根据产品，全球脊椎生物製剂市场如何分布？
  • 根据手术类型，全球脊椎生物製剂市场如何分布？
  • 根据最终用户，全球脊椎生物製剂市场如何分布？
  • 全球脊椎生物製剂市场的主要区域有哪些？
  • 全球脊椎生物製剂市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球脊椎生物製剂市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 脊椎同种异体移植
    • 关键部分
      • 机械加工骨同种异体移植
      • 去矿骨基质
  • 骨移植替代品
    • 关键部分
      • 骨形态发生蛋白
      • 合成骨移植
  • 基于单元格的矩阵

第七章：市场区隔：依手术类型

  • 开放性脊椎手术
  • 微创脊椎手术

第 8 章：市场区隔：依最终用户

  • 医院
  • 门诊护理中心
  • 脊椎外科中心
  • 骨科诊所
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Arthrex Inc
    • Alphatec Holdings Inc.
    • Exactech Inc
    • Johnson & Johnson
    • Medtronic plc
    • NuVasive Inc
    • Orthofix Medical Inc.
    • Stryker Corporation
    • Wright Medical Group NV
    • Zimmer Biomet
Product Code: SR112025A4333

The global spine biologics market size reached USD 2.14 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.97 Billion by 2033, exhibiting a growth rate (CAGR) of 3.52% during 2025-2033. The market is driven by the widespread adoption of minimally invasive surgeries (MIS), the growing geriatric population, the growing access to healthcare services on account of inflating income levels, and the increasing incidence of spinal disorders.

Spine Biologics Market Analysis:

  • Major Market Drivers: The spine biologics market research indicates that the market is primarily driven by the increasing prevalence of spinal disorders such as disc disease and spinal stenosis, often related to aging and lifestyle factors.
  • Key Market Trends: There is a noticeable trend toward the use of biologics in spine surgeries to promote quicker recovery and better outcomes, aligning with advancements in medical technologies. In the spine biologics market forecast, the industry will witness ongoing innovation with the integration of artificial intelligence and machine learning technologies to enhance the precision and effectiveness of spine biologics.
  • Geographical Trends: North America currently leads the global market due to its advanced healthcare infrastructure, high healthcare expenditure, and awareness of spinal ailments. Moreover, the Asia-Pacific region is witnessing rapid growth according to the spine biologics market statistics owing to increasing healthcare access, rising economic standards, and a growing geriatric population.
  • Competitive Landscape: Some of the major market players in the spine biologics industry include Arthrex Inc., Alphatec Holdings Inc., Exactech Inc., Johnson & Johnson, Medtronic plc, NuVasive Inc., Orthofix Medical Inc., Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet, among many others.
  • Challenges and Opportunities: The challenges in the market include concerns over the high cost of biologic products and stringent regulatory environments that can delay product launches. As outlined in the spine biologics market overview, the growing collaborations with insurance providers and healthcare facilities hold the potential to improve access to and uptake of biologic treatments generating numerous opportunities.

Spine Biologics Market Trends:

Increasing Prevalence of Spinal Disorders

The growing occurrence of spinal disorders is affecting the spine biologics market growth. In addition, the increasing life expectancy, and lifestyle issues, are spurring the development of degenerative illnesses such as disc disease and spinal stenosis. According to the World Health Organization (WHO) in 2020 approximately 1 in 13 individuals equating to 619 million individuals experienced low back pain (LBP), a 60% increase from 1990. It is further estimated that low back pain cases will increase by around 843 million by 2050 which emphasizes the widespread nature of spinal issues. The rising number of incidences is with the age group of 80 years, and the increasing number of LBP cases occur at the age of 50-55 years. This widespread prevalence necessitates ongoing development and deployment of effective treatments, including biologics, which help promote bone growth and healing, making them critical in treating these pervasive conditions.

Rising Adoption of Minimally Invasive Surgeries (MIS)

Minimally invasive surgeries (MIS) for spinal conditions are preferred due to their less distressful nature and quicker recovery times compared to traditional open surgeries. The global market for minimally invasive surgery is projected to expand at a compound annual growth rate (CAGR) of roughly 6% during 2024-2032 as per the IMARC GROUP. It reached US$ 52.9 Billion in 2023 and anticipates the market to reach US$ 91.0 Billion by 2032. This growth is declarative of a shift in surgical methods that reduce hospital stays and recovery periods, which is particularly beneficial for spine biologics market value.

Growing Geriatric Population

The growing geriatric population is driving the spine biologics market demand. As individuals age, the risk of developing spinal disorders increases, necessitating more frequent and intensive care. As per the data from the UNITED NATIONS population aged 65 and over is expected to rise from 10% in 2022 to 16% in 2050. It is forecasted that individuals aged 65 years or above globally will double the number of children under age 5 and will be equal to the number of 12-year-old children. It means a rising number of age-associated spinal conditions, escalating the demand for treatments that are effective and minimally invasive. For instance, biologics, which aid in the natural healing processes, are particularly suited to meet these needs, aligning with the growing healthcare requirements of an aging global population.

Spine Biologics Market Segmentation:

Breakup by Product:

  • Spinal Allografts
    • Machined Bones Allograft
    • Demineralized Bone Matrix
  • Bone Graft Substitutes
    • Bone Morphogenetic Proteins
    • Synthetic Bone Grafts
  • Cell Based Matrix

Bone graft substitutes account for the majority of the market share

Bone graft substitutes offer an alternative to customary bone grafts, stipulating structural support and facilitating bone healing processes in spinal surgeries. These substitutes embrace synthetic materials, allografts, and demineralized bone matrix, and are advocated for their aptitude to endorse bone fusion and curb the need for harvesting bone from the patient's own body, minimizing surgical complications and recovery time. As per the statistics by IMARC GROUP, the global bone graft and substitute market reached US$3.2 Billion in 2023. It is estimated to reach US$ 5.1 Billion by 2032 with a compound annual growth rate (CAGR) of 5.2% during 2024-2032. Moreover, various advancements in biomaterials, regenerative medicine, and bone graft substitutes are witnessing increasing adoption in spinal procedures, thus positively increasing the spine biologic market value.

Breakup by Surgery Type:

  • Open Spine Surgery
  • Minimally Invasive Spine Surgery

Minimally invasive spine surgery holds the largest share of the industry

Minimally invasive spine surgery is primarily attributed to the growing preference for minimally invasive procedures among patients and healthcare providers. Minimally invasive spine surgery offers several advantages over traditional open surgeries, including smaller incisions, reduced blood loss, shorter hospital stays, and faster recovery times. As a result, it has gained popularity for treating various spinal conditions, such as degenerative disc disease, herniated discs, spinal stenosis, and vertebral fractures. According to the NATIONAL LIBRARY OF MEDICINE, minimally invasive spine (MIS) surgery has advanced significantly with imaging navigation systems, robotics, and endoscopy. More than 400,000 cases are accomplished in the United States annually with spine fusion being the commonly conducted and established treatment options for spine trauma, tumors, structural deformities, and degenerative disorders.

Breakup by End User:

  • Hospitals
  • Ambulatory Care Centers
  • Spinal Surgery Centers
  • Orthopedic Clinics
  • Others

Hospitals represent the leading market segment

Hospitals are major centers for specialized medical care that attract a considerable proportion of patients seeking treatments for several forms of spinal disorders including those that necessitate surgeries. Furthermore, some hospitals have dedicated spine centers or departments where they offer services, making them the preferred centers for comprehensive source care. Besides this, hospitals have strong collaborations with spine biologic manufacturers and suppliers, thereby enhancing the efficiency of the equipment. In June 2022, Xenco Medical broadened its range of devices for ambulatory surgery centers by securing Food and Drug Administration (FDA) clearance and introducing its Multilevel CerviKit for their single use. It comprises a complete suite of implants and single-use instruments for two, three, and four level procedures of the anterior cervical spine.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest spine biologics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for spine biologics.

North America's dominance in the market can be attributed to highly developed healthcare infrastructure, the high rate of innovative medical technologies' adoption, and a large patient pool with spinal disorders. For instance, as per the data from the National Spinal Cord Injury Association, approximately 450,000 individuals reside in the United States with a spinal cord injury (SCI). Annually, an estimated 17,000 new cases of SCI arise in the U.S., predominantly stemming from trauma to the vertebral column. Thus, the increasing incidence of SCI population is significantly escalating the demand for spine biologics to treat disorders across the region. Additionally, favorable reimbursement policies, strong R&D efforts, and awareness of the advantages of minimally invasive surgical procedures are generating the spine biologics market revenue in North America.

Competitive Landscape:

  • The spine biologics market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the spine biologics industry include Arthrex Inc., Alphatec Holdings Inc., Exactech Inc., Johnson & Johnson, Medtronic plc, NuVasive Inc., Orthofix Medical Inc., Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet.
  • At present, key players in the market are investing in research and innovation to develop models that outperform rivals and offer solutions sought by customers. They also work hard to ensure their products remain in the market and meet customers' demands through the development of strategic alliances, acquisitions, and expansions into new markets to penetrate more markets and meet all customer needs. For instance, in October 2023, Orthofix Medical Inc., a prominent global spine and orthopedics corporation unveiled the full commercial release of OsteoCove, which is an innovative bioactive synthetic graft, following its 510k clearance. It is offered in putty and strip forms, meticulously developed to offer exceptional bone-forming capabilities and optimal handling properties for various spine and orthopedic procedures. Moreover, excellent marketing and brand management also make their products highly demanded, which is providing a positive spine biologics market outlook.

Key Questions Answered in This Report

  • 1.How big is the global spine biologics market?
  • 2.What is the expected growth rate of the global spine biologics market during 2025-2033?
  • 3.What are the key factors driving the global spine biologics market?
  • 4.What has been the impact of COVID-19 on the global spine biologics market?
  • 5.What is the breakup of the global spine biologics market based on the product?
  • 6.What is the breakup of the global spine biologics market based on the surgery type?
  • 7.What is the breakup of the global spine biologics market based on the end user?
  • 8.What are the key regions in the global spine biologics market?
  • 9.Who are the key players/companies in the global spine biologics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Spine Biologics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Spinal Allografts
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Machined Bones Allograft
      • 6.1.2.2 Demineralized Bone Matrix
    • 6.1.3 Market Forecast
  • 6.2 Bone Graft Substitutes
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Bone Morphogenetic Proteins
      • 6.2.2.2 Synthetic Bone Grafts
    • 6.2.3 Market Forecast
  • 6.3 Cell Based Matrix
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Surgery Type

  • 7.1 Open Spine Surgery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Minimally Invasive Spine Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Care Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Spinal Surgery Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Orthopedic Clinics
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Arthrex Inc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Alphatec Holdings Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Exactech Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Johnson & Johnson
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Medtronic plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 NuVasive Inc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Orthofix Medical Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Stryker Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Wright Medical Group N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Zimmer Biomet
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Spine Biologics Market: Major Drivers and Challenges
  • Figure 2: Global: Spine Biologics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Spine Biologics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Spine Biologics Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Spine Biologics Market: Breakup by Surgery Type (in %), 2024
  • Figure 6: Global: Spine Biologics Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Spine Biologics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Spine Biologics (Spinal Allografts) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Spine Biologics (Spinal Allografts) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Spine Biologics (Bone Graft Substitutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Spine Biologics (Bone Graft Substitutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Spine Biologics (Cell Based Matrix) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Spine Biologics (Cell Based Matrix) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Spine Biologics (Open Spine Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Spine Biologics (Open Spine Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Spine Biologics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Spine Biologics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Spine Biologics (Ambulatory Care Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Spine Biologics (Ambulatory Care Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Spine Biologics (Spinal Surgery Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Spine Biologics (Spinal Surgery Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Spine Biologics (Orthopedic Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Spine Biologics (Orthopedic Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Spine Biologics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Spine Biologics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Spine Biologics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Spine Biologics Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Spine Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Spine Biologics Industry: SWOT Analysis
  • Figure 78: Global: Spine Biologics Industry: Value Chain Analysis
  • Figure 79: Global: Spine Biologics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Spine Biologics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Spine Biologics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Spine Biologics Market Forecast: Breakup by Surgery Type (in Million USD), 2025-2033
  • Table 4: Global: Spine Biologics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Spine Biologics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Spine Biologics Market: Competitive Structure
  • Table 7: Global: Spine Biologics Market: Key Players